320 research outputs found

    Emergent particle-hole symmetry in spinful bosonic quantum Hall systems

    Full text link
    When a fermionic quantum Hall system is projected into the lowest Landau level, there is an exact particle-hole symmetry between filling fractions ν\nu and 1ν1-\nu. We investigate whether a similar symmetry can emerge in bosonic quantum Hall states, where it would connect states at filling fractions ν\nu and 2ν2-\nu. We begin by showing that the particle-hole conjugate to a composite fermion `Jain state' is another Jain state, obtained by reverse flux attachment. We show how information such as the shift and the edge theory can be obtained for states which are particle-hole conjugates. Using the techniques of exact diagonalization and infinite density matrix renormalization group, we study a system of two-component (i.e., spinful) bosons, interacting via a δ\delta-function potential. We first obtain real-space entanglement spectra for the bosonic integer quantum Hall effect at ν=2\nu=2, which plays the role of a filled Landau level for the bosonic system. We then show that at ν=4/3\nu=4/3 the system is described by a Jain state which is the particle-hole conjugate of the Halperin (221) state at ν=2/3\nu=2/3. We show a similar relationship between non-singlet states at ν=1/2\nu=1/2 and ν=3/2\nu=3/2. We also study the case of ν=1\nu=1, providing unambiguous evidence that the ground state is a composite Fermi liquid. Taken together our results demonstrate that there is indeed an emergent particle-hole symmetry in bosonic quantum Hall systems.Comment: 10 pages, 8 figures, 4 appendice

    Topological Crystalline Insulators in the SnTe Material Class

    Get PDF
    Topological crystalline insulators are new states of matter in which the topological nature of electronic structures arises from crystal symmetries. Here we predict the first material realization of topological crystalline insulator in the semiconductor SnTe, by identifying its nonzero topological index. We predict that as a manifestation of this nontrivial topology, SnTe has metallic surface states with an even number of Dirac cones on high-symmetry crystal surfaces such as {001}, {110} and {111}. These surface states form a new type of high-mobility chiral electron gas, which is robust against disorder and topologically protected by reflection symmetry of the crystal with respect to {110} mirror plane. Breaking this mirror symmetry via elastic strain engineering or applying an in-plane magnetic field can open up a continuously tunable band gap on the surface, which may lead to wide-ranging applications in thermoelectrics, infrared detection, and tunable electronics. Closely related semiconductors PbTe and PbSe also become topological crystalline insulators after band inversion by pressure, strain and alloying.Comment: submitted on Feb. 10, 2012; to appear in Nature Communications; 5 pages, 4 figure

    A simple radionuclide-driven single-ion source

    Get PDF
    We describe a source capable of producing single barium ions through nuclear recoils in radioactive decay. The source is fabricated by electroplating 148Gd onto a silicon {\alpha}-particle detector and vapor depositing a layer of BaF2 over it. 144Sm recoils from the alpha decay of 148Gd are used to dislodge Ba+ ions from the BaF2 layer and emit them in the surrounding environment. The simultaneous detection of an {\alpha} particle in the substrate detector allows for tagging of the nuclear decay and of the Ba+ emission. The source is simple, durable, and can be manipulated and used in different environments. We discuss the fabrication process, which can be easily adapted to emit most other chemical species, and the performance of the source

    Search for Neutrinoless Double-Beta Decay in 136^{136}Xe with EXO-200

    Get PDF
    We report on a search for neutrinoless double-beta decay of 136^{136}Xe with EXO-200. No signal is observed for an exposure of 32.5 kg-yr, with a background of ~1.5 x 10^{-3} /(kg yr keV) in the ±1σ\pm 1\sigma region of interest. This sets a lower limit on the half-life of the neutrinoless double-beta decay T1/20νββT_{1/2}^{0\nu\beta\beta}(136^{136}Xe) > 1.6 x 1025^{25} yr (90% CL), corresponding to effective Majorana masses of less than 140-380 meV, depending on the matrix element calculation

    Prophylactic intravenous tranexamic acid and thromboembolism in non-cardiac surgery: a systematic review, meta-analysis and trial sequential analysis

    Get PDF
    Tranexamic acid is an antifibrinolytic drug that is widely used during surgery, but there are concerns about its thromboembolic effects. We aimed to investigate the effect of prophylactic intravenous tranexamic acid on thromboembolic outcomes in patients undergoing non-cardiac surgery. The MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials were searched. Randomised controlled trials comparing intravenous tranexamic acid with placebo or no treatment in patients undergoing non-cardiac surgery were included. The primary outcome was a composite of peri-operative cardiovascular thromboembolic events, defined as any deep vein thrombosis, pulmonary embolism, myocardial ischaemia/infarction or cerebral ischaemia/infarction. A total of 191 randomised controlled trials (40,621 patients) were included in the review. The primary outcome occurred in 4.5% of patients receiving intravenous tranexamic acid compared with 4.9% of patients in the control group. Our analysis showed that there was no difference between groups for composite cardiovascular thromboembolic events (risk ratio 1.02, 95%CI 0.94–1.11, p = 0.65, I2 0%, n = 37,512). This finding remained robust when sensitivity analysis was performed with continuity correction and in studies with a low risk of bias. However, in trial sequential analysis, our meta-analysis only achieved 64.6% of the required information size. There was no association between intravenous tranexamic acid and seizure rate or mortality rate within 30 days. Intravenous tranexamic acid was associated with a reduced blood transfusion rate compared with control (9.9% vs. 19.4%, risk ratio 0.46, 95%CI 0.41–0.51, p < 0.0001). It was encouraging to see the evidence that the administration of intravenous tranexamic in patients undergoing non-cardiac surgery was not associated with an increased risk of thromboembolic outcomes. However, our trial sequential analysis demonstrated that currently available evidence is not yet sufficient to reach a firm conclusion
    corecore